4-propionyloxy-4-phenyl-n-methylpiperidine has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabot, MC; Cao, Ht; Geffen, V; Giuliano, AE; Han, TY; Lavie, Y; Lucci, A; Volner, A | 1 |
| Banerjee, S; Basu, M; Basu, S; Boyle, PJ; Bradley, M; Ma, R; Mikulla, B; Smith, B | 1 |
2 other study(ies) available for 4-propionyloxy-4-phenyl-n-methylpiperidine and tamoxifen
| Article | Year |
|---|---|
Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
Topics: Ceramides; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glycosphingolipids; Glycosylation; Humans; Meperidine; Tamoxifen; Tumor Cells, Cultured; Verapamil | 1997 |
Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis -platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside.
Topics: Antineoplastic Agents; Apoptosis; Betulinic Acid; Caspase 3; Caspases; Cell Line, Tumor; Cell Nucleus; Cisplatin; DNA; DNA Helicases; DNA Polymerase I; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Fluorescent Dyes; Gangliosides; Glycosphingolipids; Humans; Melphalan; Meperidine; Microscopy, Fluorescence; Models, Biological; Models, Chemical; Morpholines; Pentacyclic Triterpenes; Propidium; Signal Transduction; Sphingolipids; Tamoxifen; Time Factors; Triterpenes; Zinc Fingers | 2004 |